Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0002022308-25-000002
Filing Date
2025-07-09
Accepted
2025-07-09 12:33:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5236
  Complete submission text file 0002022308-25-000002.txt   6995
Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Subject) CIK: 0001837607 (see all company filings)

EIN.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-92271 | Film No.: 251112827
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 29 VALENTINES LANE OLD BROOKVILLE NY 11545
Business Address 29 VALENTINES LANE OLD BROOKVILLE NY 11545 5169674430
Alta Partners LLC (Filed by) CIK: 0001896206 (see all company filings)

EIN.: 451743500 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SCHEDULE 13G/A